We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCK icon
351
Crown Holdings
CCK
$13.2B
-213,370
Closed -$17.6M
CDE icon
352
Coeur Mining
CDE
$16.1B
-800,000
Closed -$4.58M
CDLX icon
353
Cardlytics
CDLX
$20.7M
-45,000
Closed -$1.67M
CFLT
354
DELISTED
Confluent
CFLT
-262,500
Closed -$7.34M
CGON icon
355
CG Oncology
CGON
$6.6B
-12,834
Closed -$368K
CLH icon
356
Clean Harbors
CLH
$16.2B
-17,200
Closed -$3.96M
CORT icon
357
CALL
Corcept Therapeutics
CORT
$11.7B
-40,000
Closed -$17.5K
COTY icon
358
PUT
Coty
COTY
$2.39B
-1,264,500
Closed -$1.62M
CPRI icon
359
PUT
Capri Holdings
CPRI
$1.7B
-12,600
Closed -$494K
CRGX
360
DELISTED
CARGO Therapeutics
CRGX
-26,899
Closed -$388K
CRSP icon
361
CALL
CRISPR Therapeutics
CRSP
$4.99B
-20,000
Closed -$4K
CYH icon
362
CALL
Community Health Systems
CYH
$416M
-270,000
Closed -$27K
DECK icon
363
Deckers Outdoor
DECK
$13.3B
-10,000
Closed -$2.03M
DELL icon
364
Dell
DELL
$283B
-4,000
Closed -$461K
DNLI icon
365
Denali Therapeutics
DNLI
$3.92B
-21,039
Closed -$429K
DOW icon
366
Dow Inc
DOW
$21.9B
-261,700
Closed -$10.5M
DTIL icon
367
Precision BioSciences
DTIL
$205M
-15,534
Closed -$59.2K
DXCM icon
368
CALL
DexCom
DXCM
$31.3B
-20,000
Closed -$108K
DYN icon
369
CALL
Dyne Therapeutics
DYN
$4.83B
-20,000
Closed -$49K
ELF icon
370
e.l.f. Beauty
ELF
$5.44B
-7,500
Closed -$942K
EPR icon
371
PUT
EPR Properties
EPR
$4.7B
-25,700
Closed -$1.93K
ESTC icon
372
Elastic
ESTC
$7.27B
-5,000
Closed -$495K
EWTX icon
373
CALL
Edgewise Therapeutics
EWTX
$4.78B
-15,000
Closed -$4.88K
FFIV icon
374
F5
FFIV
$23.5B
-6,000
Closed -$1.51M
FLR icon
375
Fluor
FLR
$6.81B
-106,130
Closed -$5.23M

Similar funds

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.